Dr HANNAH CROSSLAND Hannah.Crossland1@nottingham.ac.uk
RESEARCH FELLOW
Peroxisome proliferator-activated receptor γ agonism attenuates endotoxaemia-induced muscle protein loss and lactate accumulation in rats
Crossland, Hannah; Constantin-Teodosiu, Dumitru; Gardiner, Sheila M.; Greenhaff, PaulL.
Authors
Dumitru Constantin-Teodosiu
Sheila M. Gardiner
Professor PAUL GREENHAFF PAUL.GREENHAFF@NOTTINGHAM.AC.UK
PROFESSOR OF MUSCLE METABOLISM
Abstract
The peroxisome proliferator-activated receptor γ (PPARγ) agonist rosiglitazone (Rosi) appears to provide protection against organ dysfunction during endotoxaemia. We examined the potential benefits of Rosi on skeletal muscle protein maintenance and carbohydrate metabolism during lipopolysaccharide (LPS)-induced endotoxaemia. Sprague-Dawley rats were fed either standard chow (control) or standard chow containing Rosi (8.5±0.1 mg.kg-1.day-1) for two weeks before and during 24 h continuous intravenous infusion of LPS (15 μg.kg-1.h-1) or saline. Rosi blunted LPS-induced increases in muscle tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) mRNA by 70% (P<0.05) and 64% (P<0.01), respectively. Furthermore, Rosi suppressed the LPS-induced reduction in phosphorylated AKT and phosphorylated Forkhead box O (FOXO) 1 protein, as well as the upregulation of muscle RING finger 1 (MuRF1; P<0.01) mRNA, and the LPS-induced increase in 20S proteasome activity (P<0.05). Accordingly, LPS reduced the muscle protein:DNA ratio (~30%, P<0.001), which Rosi offset. Increased muscle pyruvate dehydrogenase kinase 4 (PDK4) mRNA (P<0.001) and muscle lactate accumulation (P<0.001) during endotoxaemia were suppressed by Rosi. Thus, pre-treatment with Rosi reduced muscle cytokine accumulation and blunted muscle protein loss and lactate accumulation during endotoxaemia, and at least in part by reducing activation of molecular events known to increase muscle protein breakdown and mitochondrial pyruvate use.
Citation
Crossland, H., Constantin-Teodosiu, D., Gardiner, S. M., & Greenhaff, P. (2017). Peroxisome proliferator-activated receptor γ agonism attenuates endotoxaemia-induced muscle protein loss and lactate accumulation in rats. Clinical Science, 131(13), 1437-1447. https://doi.org/10.1042/CS20170958
Journal Article Type | Article |
---|---|
Acceptance Date | May 23, 2017 |
Online Publication Date | May 23, 2017 |
Publication Date | Jul 1, 2017 |
Deposit Date | Jul 17, 2017 |
Publicly Available Date | Jul 17, 2017 |
Journal | Clinical Science |
Print ISSN | 0143-5221 |
Electronic ISSN | 1470-8736 |
Publisher | Portland Press |
Peer Reviewed | Peer Reviewed |
Volume | 131 |
Issue | 13 |
Pages | 1437-1447 |
DOI | https://doi.org/10.1042/CS20170958 |
Keywords | sepsis, inflammation, muscle atrophy, muscle insulin resistance |
Public URL | https://nottingham-repository.worktribe.com/output/867524 |
Publisher URL | http://www.clinsci.org/content/131/13/1437 |
Contract Date | Jul 17, 2017 |
Files
Rosi Published_.full.pdf
(1.2 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Molecular Transducers of Human Skeletal Muscle Remodeling under Different Loading States
(2020)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search